New Proteins Could Aid Cancer, Heart Treatments
Posted on: Thursday, 3 July 2003, 06:00 CDT
Scientists discover new class of proteins that spur blood vessel development
HealthDayNews -- California cancer researchers have discovered a new class of proteins that spurs the development of blood vessels -- a finding that could aid in the treatment of cancer, heart disease and more.
Newly named as "angiomatrix" proteins, they promote angiogenesis, the process by which the body forms new blood vessels, the researchers say.
A report on their finding, in the July 1 issue of the Journal of Clinical Investigation, describes how one such protein, the Del-1 protein, initiates angiogenesis by locking onto a cell membrane using a previously unknown cell adhesion receptor, the alpha-v-beta-5. It then activates a transcription factor called Hox D3, which initiates a chain of events that changes the cell profile -- and makes it angiogenic.
"In the cancer setting, you want to inhibit angiogenesis," writes lead researcher Judith Varner, an associate adjunct professor of medicine at the University of California, San Diego. "Knowing the mechanism will help us design therapies that can inhibit Del-1."
On the other hand, researchers looking for new ways treat heart disease want to know how to promote angiogenesis.
------
On the Net:
University of California, San Diego
More science, space, and technology from RedNova
Copyright © 2003 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment. Medical information changes rapidly and while Yahoo and its content providers make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.
Related Articles
- Consumer Group Wants Public to Share Profits From Federally Funded Stem Cell and Medical Research
- Two Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimer's Disease
- California Stem Cell Agency Exaggerated Its Role in Funding Key Research
- Aethlon Medical to Present at Tommorow's California Equity Research Investor Conference
- Argos Therapeutics' Scientific Founder Ralph Steinman, M.D., Receives Lasker Award for Basic Medical Research
- Aethlon Medical Signs Cooperative Research and Development Agreement With The U.S. Army Medical Research Institute of Infectious Diseases
- H. Lee Moffitt Researchers Discover Potential Targets to Reduce Risk of Stem Cell Transplants
- ADDING MULTIMEDIA MetLife Foundation Marks 20th Anniversary of Awards for Medical Research in Alzheimer's Disease; Two Decades of Investing in Science and Scientists
- Okla. Medical Research Found.-Based Drug Found Highly Effective in Treating Rare Blood Disorder
- Spectrum Pharmaceuticals Presents Data on SPI-1620 at the Annual Meeting of the American Association of Cancer Research (AACR), in Anaheim, California
 |
 |
User Comments (0)
RSS Feeds